Hermoso-Durán Sonia, Domper-Arnal María José, Roncales Pilar, Vega Sonia, Sanchez-Gracia Oscar, Ojeda Jorge L, Lanas Ángel, Velazquez-Campoy Adrian, Abian Olga
Institute of Biocomputation and Physics of Complex Systems (BIFI), Joint Unit GBsC-CSIC-BIFI, University of Zaragoza, 50018 Zaragoza, Spain.
Aragón Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.
Cancers (Basel). 2023 Mar 24;15(7):1952. doi: 10.3390/cancers15071952.
(1) Background: About 50% of prescribed colonoscopies report no pathological findings. A secondary screening test after fecal immunochemical test positivity (FIT+) would be required. Considering thermal liquid biopsy (TLB) as a potential secondary test, the aim of this work was to study possible interferences of colonoscopy bowel preparation on TLB outcome on a retrospective study; (2) Methods: Three groups were studied: 1/514 FIT(+) patients enrolled in a colorectal screening program (CN and CP with normal and pathological colonoscopy, respectively), with blood samples obtained just before colonoscopy and after bowel preparation; 2/55 patients from the CN group with blood sample redrawn after only standard 8-10 h fasting and no bowel preparation (CNR); and 3/55 blood donors from the biobank considered as a healthy control group; (3) Results: The results showed that from the 514 patients undergoing colonoscopy, 247 had CN and 267 had CP. TLB parameters in these two groups were similar but different from those of the blood donors. The resampled patients (with normal colonoscopy and no bowel preparation) had similar TLB parameters to those of the blood donors. TLB parameters together with fluorescence spectra and other serum indicators (albumin and C-reactive protein) confirmed the statistically significant differences between normal colonoscopy patients with and without bowel preparation; (4) Conclusions: Bowel preparation seemed to alter serum protein levels and altered TLB parameters (different from a healthy subject). The diagnostic capability of other liquid-biopsy-based methods might also be compromised. Blood extraction after bowel preparation for colonoscopy should be avoided.
(1) 背景:约50%的结肠镜检查报告无病理结果。粪便免疫化学检测呈阳性(FIT+)后需要进行二次筛查测试。考虑到热液体活检(TLB)作为一种潜在的二次检测方法,本研究旨在通过回顾性研究探讨结肠镜肠道准备对TLB结果的可能干扰;(2) 方法:研究了三组:1/514名参加结直肠癌筛查项目的FIT(+)患者(分别为结肠镜检查正常和异常的CN组和CP组),在结肠镜检查前和肠道准备后采集血样;2/55名来自CN组的患者,仅在标准禁食8 - 10小时且未进行肠道准备后重新采集血样(CNR);3/55名来自生物样本库的献血者作为健康对照组;(3) 结果:结果显示,在接受结肠镜检查的514名患者中,247人结肠镜检查正常(CN),267人异常(CP)。这两组的TLB参数相似,但与献血者的不同。重新采样的患者(结肠镜检查正常且未进行肠道准备)的TLB参数与献血者的相似。TLB参数连同荧光光谱和其他血清指标(白蛋白和C反应蛋白)证实了有和没有肠道准备的正常结肠镜检查患者之间存在统计学上的显著差异;(4) 结论:肠道准备似乎会改变血清蛋白水平并改变TLB参数(与健康受试者不同)。其他基于液体活检的方法的诊断能力也可能受到影响。应避免在结肠镜检查肠道准备后采血。